These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 19411680

  • 1. High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.
    Frange P, Galimand J, Goujard C, Deveau C, Ghosn J, Rouzioux C, Meyer L, Chaix ML.
    J Antimicrob Chemother; 2009 Jul; 64(1):135-41. PubMed ID: 19411680
    [Abstract] [Full Text] [Related]

  • 2. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
    Seclén E, Garrido C, González Mdel M, González-Lahoz J, de Mendoza C, Soriano V, Poveda E.
    J Antimicrob Chemother; 2010 Jul; 65(7):1486-92. PubMed ID: 20427374
    [Abstract] [Full Text] [Related]

  • 3. HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples.
    Saracino A, Monno L, Punzi G, Cibelli DC, Tartaglia A, Scudeller L, Brindicci G, Lagioia A, Scotto G, Angarano G.
    Virus Res; 2007 Dec; 130(1-2):34-42. PubMed ID: 17582634
    [Abstract] [Full Text] [Related]

  • 4. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.
    Clin Infect Dis; 2008 May 15; 46(10):1617-23. PubMed ID: 18419499
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
    de Mendoza C, Rodriguez C, García F, Eiros JM, Ruíz L, Caballero E, Aguilera A, Leiva P, Colomina J, Gutierrez F, del Romero J, Aguero J, Soriano V, Spanish HIV Seroconverter Study Group.
    J Antimicrob Chemother; 2007 Apr 15; 59(4):698-704. PubMed ID: 17327295
    [Abstract] [Full Text] [Related]

  • 6. Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection.
    Frange P, Chaix ML, Raymond S, Galimand J, Deveau C, Meyer L, Goujard C, Rouzioux C, Izopet J, French ANRS CO 06 PRIMO Cohort Study Group.
    J Clin Microbiol; 2010 Oct 15; 48(10):3487-91. PubMed ID: 20686090
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C, Roulet V, Chueca N, Poveda E, Aguilera A, Skrabal K, Zahonero N, Carlos S, García F, Faudon JL, Soriano V, de Mendoza C.
    J Clin Microbiol; 2008 Mar 15; 46(3):887-91. PubMed ID: 18199789
    [Abstract] [Full Text] [Related]

  • 8. Construction and characterization of a full-length infectious clone from a fast-replicating, X4-tropic HIV-1 subtype B' isolate.
    Wu SL, Yan YS, Yan PP, Huang HL, Wang HR.
    Arch Virol; 2010 Dec 15; 155(12):1923-31. PubMed ID: 20697919
    [Abstract] [Full Text] [Related]

  • 9. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    Ghosn J, Pellegrin I, Goujard C, Deveau C, Viard JP, Galimand J, Harzic M, Tamalet C, Meyer L, Rouzioux C, Chaix ML, French PRIMO Cohort Study Group (ANRS CO 06).
    AIDS; 2006 Jan 09; 20(2):159-70. PubMed ID: 16511408
    [Abstract] [Full Text] [Related]

  • 10. Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
    Soulié C, Charpentier C, Flandre P, Nino C, Carcelain G, Simon A, Katlama C, Landman R, Brun-Vézinet F, Descamps D, Calvez V, Marcelin AG.
    J Med Virol; 2012 Dec 09; 84(12):1853-6. PubMed ID: 23080487
    [Abstract] [Full Text] [Related]

  • 11. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V, Balestra E, Cento V, Sarmati L, Dori L, Vandenbroucke I, D'Arrigo R, Buonomini AR, Van Marck H, Surdo M, Saccomandi P, Mostmans W, Aerssens J, Aquaro S, Stuyver LJ, Andreoni M, Ceccherini-Silberstein F, Perno CF.
    Antiviral Res; 2011 Apr 09; 90(1):42-53. PubMed ID: 21349294
    [Abstract] [Full Text] [Related]

  • 12. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.
    AIDS; 2008 Jul 31; 22(12):1425-31. PubMed ID: 18614865
    [Abstract] [Full Text] [Related]

  • 13. Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort.
    Ghosn J, Deveau C, Chaix ML, Goujard C, Galimand J, Zitoun Y, Allègre T, Delfraissy JF, Meyer L, Rouzioux C, ANRS PRIMO Cohort.
    J Antimicrob Chemother; 2010 Apr 31; 65(4):741-8. PubMed ID: 20167586
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C, Fourati S, Lambert-Niclot S, Malet I, Wirden M, Tubiana R, Valantin MA, Katlama C, Calvez V, Marcelin AG.
    J Antimicrob Chemother; 2010 Apr 31; 65(4):749-51. PubMed ID: 20150182
    [Abstract] [Full Text] [Related]

  • 15. Predominance of CXCR4 tropism in HIV-1 CRF14_BG strains from newly diagnosed infections.
    Pérez-Álvarez L, Delgado E, Vega Y, Montero V, Cuevas T, Fernández-García A, García-Riart B, Pérez-Castro S, Rodríguez-Real R, López-Álvarez MJ, Fernández-Rodríguez R, Lezaun MJ, Ordóñez P, Ramos C, Bereciartua E, Calleja S, Sánchez-García AM, Thomson MM.
    J Antimicrob Chemother; 2014 Jan 31; 69(1):246-53. PubMed ID: 23900735
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.
    Delgado E, Fernández-García A, Vega Y, Cuevas T, Pinilla M, García V, Sánchez M, González M, Sánchez AM, Thomson MM, Pérez-Álvarez L.
    J Antimicrob Chemother; 2012 Jan 31; 67(1):25-31. PubMed ID: 22010208
    [Abstract] [Full Text] [Related]

  • 17. Comparison of two genotypic algorithms to determine HIV-1 tropism.
    Soulié C, Derache A, Aimé C, Marcelin AG, Carcelain G, Simon A, Katlama C, Calvez V.
    HIV Med; 2008 Jan 31; 9(1):1-5. PubMed ID: 18199166
    [Abstract] [Full Text] [Related]

  • 18. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW.
    J Infect Dis; 2005 Mar 15; 191(6):890-8. PubMed ID: 15717264
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.
    Briz V, García D, Méndez-Lagares G, Ruiz-Mateos E, de Mulder M, Moreno-Pérez D, Navarro ML, León-Leal JA, de José MI, Ramos JT, Mellado MJ, González-Tomé MI, Leal M, Muñoz-Fernández MA.
    Pediatr Infect Dis J; 2012 Oct 15; 31(10):1048-52. PubMed ID: 22828644
    [Abstract] [Full Text] [Related]

  • 20. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain.
    Pérez-Alvarez L, Muñoz M, Delgado E, Miralles C, Ocampo A, García V, Thomson M, Contreras G, Nájera R, Spanish Group for Antiretroviral Resistance Studies in Galicia.
    J Med Virol; 2006 Dec 15; 78(12):1520-8. PubMed ID: 17063519
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.